Europe Respiratory/Pulmonary

• The Market and Future Potential for Molecular Point of Care

  Mar 11, 2020  |  Published by: Kalorama Information  |  USD 6,000

  ... times and usability in near-patient settings. Major IVD companies such as Abbott and Roche compete in this segment, influenza competitors Sekisui and Quidel also operate, as do specialty concerns such as Curetis, Biocartis, and a ... Read More

< prev 1 2 3 4 next >